ÿþ<HTML><HEAD><TITLE>25º Congresso Brasileiro de Microbiologia </TITLE><link rel=STYLESHEET type=text/css href=css.css></HEAD><BODY aLink=#ff0000 bgColor=#FFFFFF leftMargin=0 link=#000000 text=#000000 topMargin=0 vLink=#000000 marginheight=0 marginwidth=0><table align=center width=700 cellpadding=0 cellspacing=0><tr><td align=left bgcolor=#cccccc valign=top width=550><font face=arial size=2><strong><font face=Verdana, Arial, Helvetica, sans-serif size=3><font size=1>25º Congresso Brasileiro de Microbiologia </font></font></strong><font face=Verdana size=1><b><br></b></font><font face=Verdana, Arial,Helvetica, sans-serif size=1><strong> </strong></font></font></td><td align=right bgcolor=#cccccc valign=top width=150><font face=arial size=2><strong><font face=Verdana, Arial, Helvetica, sans-serif size=1><font size=1>ResumoID:127-1</font></em></font></strong></font></td></tr><tr><td colspan=2><br><br><table align=center width=700><tr><td>Área: <b>Microbiologia de Alimentos ( Divisão K )</b><p align=justify><strong>EVALUATION OF THE ROLES OF THE ENVIRONMENTAL FACTORS IN THE HUMAN GIT ON THE BEHAVIOUR OF PROBIOTIC CULTURES <EM>L. CASEI</EM> SHIROTA AND LC01 BY THE USE OF <EM>IN VITRO</EM> MODEL</strong></p><p align=justify><b>Katia Gianni de Carvalho </b> (<i>USP</i>); <b>Monika Francisca Kruger </b> (<i>USP</i>); <b>Danielle Nader Furtado </b> (<i>USP</i>); <b><u>Svetoslav Dimitrov Todorov </u></b> (<i>USP</i>); <b>Bernadette Dora Gombossy de Melo Franco </b> (<i>USP</i>)<br><br></p><b><font size=2>Resumo</font></b><p align=justify class=tres><font size=2><P class=MsoNormal style="MARGIN: 0cm 0cm 0pt; TEXT-ALIGN: justify"><SPAN lang=EN-US>This study evaluated the influence of gastrointestinal environmental factors (pH, digestive enzymes, food components, medicaments) on the survival of <I>Lactobacillus casei </I>Shirota and <I>Lactobacillus casei </I>LC01, using a semi-dynamic <I>in vitro </I>model that simulates the transit of microorganisms through the human GIT. The strains were first exposed to different simulated gastric juices for different periods of time (0, 30, 60 and 120 min), and then to simulated intestinal fluids for zero, 120, 180 and 240 min, in a step-wise format. The number of viable cells was determined after each step. The influence of food residues (skim milk) in the fluids and resistance to medicaments commonly used for varied therapeutic purposes were also evaluated. </SPAN></P> <P class=MsoBodyText2 style="MARGIN: 0cm 0cm 0pt; TEXT-INDENT: 35.45pt; LINE-HEIGHT: normal; tab-stops: 0cm" align=justify><SPAN lang=EN-US style="FONT-WEIGHT: normal; FONT-FAMILY: 'Times New Roman','serif'; mso-bidi-font-weight: bold">As recorded in our study, both <I style="mso-bidi-font-style: normal">L. casei </I>Shirota and <I style="mso-bidi-font-style: normal">L. casei</I> LC01 were inhibited by non-steroidal anti-inflammatory drugs (NSAID) containing diclofenac potassium or ibuprofen arginine as well as by the two antibiotics tested. In addition, <I style="mso-bidi-font-style: normal">L. casei</I> Shirota was affected by <A title="Selective serotonin reuptake inhibitor" href="http://en.wikipedia.org/wiki/Selective_serotonin_reuptake_inhibitor"><SPAN style="COLOR: windowtext; TEXT-DECORATION: none; text-underline: none">selective serotonin reuptake inhibitor</SPAN></A>s (SSRI) <A title=Antidepressant href="http://en.wikipedia.org/wiki/Antidepressant"><SPAN style="COLOR: windowtext; TEXT-DECORATION: none; text-underline: none">antidepressant</SPAN></A> containing paroxetine and antiarrhythmic medication containing amiodarone. <I style="mso-bidi-font-style: normal">L. casei</I> LC01 was inhbited by hypolipidemic medication containing simvastatin.<SPAN style="mso-spacerun: yes">&nbsp; </SPAN><?xml:namespace prefix = o ns = "urn:schemas-microsoft-com:office:office" /><o:p></o:p></SPAN></P> <P class=MsoNormal style="MARGIN: 0cm 0cm 0pt; TEXT-INDENT: 35.4pt; TEXT-ALIGN: justify"><SPAN lang=EN-US>The correct evaluation of possible interactions between medicaments and probiotic bacteria depends on the determination of MIC of these medicaments. The MIC for Spidufen, an anti-inflamatory and anti-rheumatic drug, was 40 mg/mL for both <I style="mso-bidi-font-style: normal">L. casei </I>Shirota and <I style="mso-bidi-font-style: normal">L. casei</I> LC01. Considering that the daily dose for this medicament is 600 mg, the MIC value associated to the volume of the human GIT indicate that the recommended daily dose will hardly affect the survival of the probiotic bacteria. More important are the medicaments for treatment of chronic diseases, such as Zocor, an anti-lipemic drug used for the reduction of the body lipids, Atlansil, an anti-arrhytmic drug normally used in long course treatments and Arotin, a drug from the group of the anti-depressants with neuroleptic effect, also used in long-term treatments, which presented MIC of 1.0 mg/ml, 1.25 mg/ml and 1.0 mg/ml, respectively. Due to their long-term application, they can accumulate in the gastrointestinal tract and affect the viability of the probiotic cultures.<SPAN style="mso-spacerun: yes">&nbsp; </SPAN></SPAN></P></font></p><br><b>Palavras-chave: </b>&nbsp;GIT, LAB, Lactobacillus casei Shirota, Lactobacillus casei LC01, probiotic</td></tr></table></tr></td></table></body></html>